Affiliations 

  • 1 Endocrine Unit, Putrajaya Hospital, Wilayah Persekutuan Putrajaya, Malaysia
J ASEAN Fed Endocr Soc, 2018;33(1):53-56.
PMID: 33442111 DOI: 10.15605/jafes.033.01.09

Abstract

We present a case of a 27-year-old female with T2 DM who developed allergic reactions after commencement of insulin therapy. Trial with different types of insulin resulted in a series of allergic reactions ranging from urticarial rash to development of angioedema, bronchospasm and anaphylactic shock. She was successfully treated with a modified insulin desensitization protocol using rapid-acting insulin.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.